|
|
||||||||
RESEARCH AND PRACTICE |
Grace E. Macalino is with the Institute for Clinical Research and Health Policy Studies, Tufts New England Medical Center, Boston, Mass. Darpun Dhawan is with Brown Medical School, Providence, RI. Josiah D. Rich is with the Department of Medicine and Community Health, Brown University and the Center for Prisoner Health and Human Rights at The Miriam Hospital, Providence, RI.
Correspondence: Requests for reprints should be sent to Grace E. Macalino, PhD, Institute for Clinical Research and Health Policy Studies, Tufts New England Medical Center, 750 Washington St, Box 63, Boston, MA 02111 (e-mail: gmacalino{at}tufts-nemc.org).
In 2003, the Centers for Disease Control and Prevention issued recommendations to screen all inmates with a history of injection drug use or other risk factors for hepatitis C. We compared self-reported risk factors for hepatitis C with serostatus from inmates in the Rhode Island Department of Corrections. Of the male inmates who were hepatitis C positive, 66% did not report injection drug use. Risk-based testing underestimates the hepatitis C virus (HCV) prevalence in correctional settings and limits the opportunity to diagnose and prevent hepatitis C infection.
This article has been cited by other articles:
![]() |
M F Vescio, B Longo, S Babudieri, G Starnini, S Carbonara, G Rezza, and R Monarca Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis J. Epidemiol. Community Health, April 1, 2008; 62(4): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |